Barbara Grün

805 total citations
33 papers, 533 citations indexed

About

Barbara Grün is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Barbara Grün has authored 33 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Barbara Grün's work include Cancer Cells and Metastasis (5 papers), Reproductive Biology and Fertility (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Barbara Grün is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Reproductive Biology and Fertility (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Barbara Grün collaborates with scholars based in Germany, United Kingdom and United States. Barbara Grün's co-authors include Simon A. Gayther, Ian Jacobs, Kate Lawrenson, Dimitra Dafou, Elizabeth Benjamin, Klaus‐Dieter Riedel, Johanna Weiß, Walter E. Haefeli, Norbert Dahmen and Geraldine Rauch and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Clinical Cancer Research.

In The Last Decade

Barbara Grün

33 papers receiving 525 citations

Peers

Barbara Grün

ONCOL

IMMUN

Li Lyu China

Rogério Dias Brazil

Fiona O’Mahony Ireland

Mélanie Sanchez Canada

Gautam G. Rao United States

Péter Ugocsai Germany

Ming G. Chai Australia

Cadmon K.P. Lim Hong Kong

Jude Abadie United States

Stefanie Petzold Germany

Li Lyu China

Barbara Grün

226 ×1.0

ONCOL

231 ×1.5

46 ×0.4

IMMUN

80 ×1.3

52 ×1.0

Citations per year, relative to Barbara Grün Barbara Grün (= 1×) peers Li Lyu

Countries citing papers authored by Barbara Grün

Since Specialization

Citations

This map shows the geographic impact of Barbara Grün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Grün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Grün more than expected).

Fields of papers citing papers by Barbara Grün

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Grün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Grün. The network helps show where Barbara Grün may publish in the future.

Co-authorship network of co-authors of Barbara Grün

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Grün. A scholar is included among the top collaborators of Barbara Grün based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Grün. Barbara Grün is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fottner, Christian, Leonidas Apostolidis, Sebastian Krug, et al.. (2024). Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial). Clinical Cancer Research. 31(5). 860–867. 3 indexed citations

Tintelnot, Joseph, Alexander Stein, Salah‐Eddin Al‐Batran, et al.. (2023). Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321). Frontiers in Oncology. 13. 1272175–1272175. 3 indexed citations

Haag, Georg Martin, Christoph Springfeld, Barbara Grün, et al.. (2022). Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial. European Journal of Cancer. 167. 112–122. 77 indexed citations

Valentini, Jan, Cornelia Mahler, Peter Martus, et al.. (2022). Interprofessional evidence-based counselling programme for complementary and integrative healthcare in patients with cancer: study protocol for the controlled implementation study CCC-Integrativ. BMJ Open. 12(2). e055076–e055076. 11 indexed citations

Lawrenson, Kate, Barbara Grün, Nathan Lee, et al.. (2014). NPPB is a novel candidate biomarker expressed by cancer‐associated fibroblasts in epithelial ovarian cancer. International Journal of Cancer. 136(6). 1390–1401. 26 indexed citations

Grün, Barbara, Michael K. Kießling, Jürgen Burhenne, et al.. (2013). Trimethoprim–metformin interaction and its genetic modulation by OCT2 and MATE1 transporters. British Journal of Clinical Pharmacology. 76(5). 787–796. 65 indexed citations

Grün, Barbara, et al.. (2012). Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine. British Journal of Clinical Pharmacology. 74(5). 854–863. 11 indexed citations

Lawrenson, Kate, Barbara Grün, & Simon A. Gayther. (2012). Heterotypic Three-dimensional <em>In Vitro</em> Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression. Journal of Visualized Experiments. e4206–e4206. 15 indexed citations

Lawrenson, Kate, Duncan Sproul, Barbara Grün, et al.. (2011). Modelling genetic and clinical heterogeneity in epithelial ovarian cancers. Carcinogenesis. 32(10). 1540–1549. 27 indexed citations

10.

Dafou, Dimitra, Barbara Grün, Kate Lawrenson, et al.. (2010). Microcell-Mediated Chromosome Transfer Identifies EPB41L3 as a Functional Suppressor of Epithelial Ovarian Cancers. Neoplasia. 12(7). 579–IN18. 44 indexed citations

11.

Broge, Björn, et al.. (2010). Bildung einer Kontrollgruppe mithilfe von Matched-Pairs auf Basis von GKV-Routinedaten zur prospektiven Evaluation von Einschreibemodellen. Das Gesundheitswesen. 72(6). 363–370. 2 indexed citations

12.

Häfner, Verena, Barbara Grün, Christoph Markert, et al.. (2010). Arzneimittelinteraktionen. Der Internist. 51(3). 359–370. 2 indexed citations

13.

Lawrenson, Kate, Barbara Grün, Elizabeth Benjamin, et al.. (2010). Senescent Fibroblasts Promote Neoplastic Transformation of Partially Transformed Ovarian Epithelial Cells in a Three-dimensional Model of Early Stage Ovarian Cancer. Neoplasia. 12(4). 317–IN3. 76 indexed citations

14.

Laux, Gunter, et al.. (2009). Antihypertensive medikamentöse Therapie von gesetzlich und privat versicherten Patienten in der Primärversorgung. Medizinische Klinik. 104(2). 108–113. 4 indexed citations

15.

Grün, Barbara, Elizabeth Benjamin, John F. Timms, et al.. (2009). Three‐dimensional in vitro cell biology models of ovarian and endometrial cancer. Cell Proliferation. 42(2). 219–228. 52 indexed citations

16.

Grün, Barbara, et al.. (2009). Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole. British Journal of Clinical Pharmacology. 68(5). 712–720. 10 indexed citations

17.

Grün, Barbara, et al.. (2008). Bestimmung der Verschlußlänge in Extremitätenarterien - Farbduplexsonographie versus Angiographie. Ultraschall in der Medizin - European Journal of Ultrasound. 14(5). 247–254. 2 indexed citations

18.

Dafou, Dimitra, Susan J. Ramus, Barbara Grün, et al.. (2008). Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells. International Journal of Cancer. 124(5). 1037–1044. 8 indexed citations

19.

Grün, Barbara, et al.. (2008). Farbkodierte Duplexsonographie in der Diagnostik von Nierenarterienstenosen^*. DMW - Deutsche Medizinische Wochenschrift. 118(40). 1429–1436. 5 indexed citations

20.

Grün, Barbara, et al.. (1995). Perkutane transluminale Angioplastie der Arteria profunda femoris. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 163(8). 163–170. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact